As Gilead begins to streamline the process for COVID-19 patients to receive its experimental antiviral remdesivir on a wider basis, the company also raised some eyebrows on Monday by obtaining an ...

In a reversal, Gilead said Wednesday that it submitted a request to the US Food and Drug Administration (FDA) to rescind the orphan drug designation it was granted for the investigational antiviral ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. Next year, California will set up ...

California will start trust accounts for children from low-income families who lost a parent or guardian to Covid-19, the LAist reported. First, the state has to identify the eligible kids. The ...